SmithRx
Pharmacy
OVERVIEW: SmithRx is redefining the pharmacy benefit management (PBM) landscape by tackling the rising cost of prescription drugs with a combination of advanced technology, strategic partnerships and transparency. Its flagship Connect 360 program ensures members access the lowest net cost for medications by evaluating cost variables, recommending generics or biosimilars and collaborating with vendors such as Mark Cuban Cost Plus Drugs. Clients benefit from SmithRx’s 100% pass-through model, sharing all rebates and savings directly.
IMPACT ACHIEVED: Delivering tangible results, SmithRx achieves an average 20% reduction in drug prices for clients. A standout example of its impact is the case of Teriflunomide, a generic multiple sclerosis medication, which costs approximately $9,600 for a month’s supply at specialty pharmacies. Through Connect 360, SmithRx reduces that cost to just $18, demonstrating an exceptional 99.8% savings.
DISTINCTIVE EDGE: By integrating cost-saving strategies, rigorous medication assessments and clinically effective alternatives, SmithRx bridges the gap between affordability and quality. Its innovative approach, coupled with transparent pricing and proactive member support, positions it as a transformative force in pharmacy benefit management, delivering value and relief to employers and patients alike.